The RNA-binding Protein IMP-3 Is a Translational Activator of Insulin-like Growth Factor II Leader-3 mRNA during Proliferation of Human K562 Leukemia Cells
Authors:
- Yan HuYHYan Hu
- David J. HerrickDHDavid J. Herrick
- Gary BrewerGBGary Brewer
Open Access
- 1 May 2005
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 280 (18) , 18517-18524
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Targeted Knockdown of the RNA-binding Protein CRD-BP Promotes Cell Proliferation via an Insulin-like Growth Factor II-dependent Pathway in Human K562 Leukemia CellsJournal of Biological Chemistry, 2004
- Dwarfism and Impaired Gut Development in Insulin-Like Growth Factor II mRNA-Binding Protein 1-Deficient MiceMolecular and Cellular Biology, 2004
- C‐MYC and IGF‐II mRNA‐binding protein (CRD‐BP/IMP‐1) in benign and malignant mesenchymal tumorsInternational Journal of Cancer, 2001
- Overexpression of an mRNA-binding protein in human colorectal cancerOncogene, 2001
- Expression of mouse igf2 mRNA‐binding protein 3 and its implications for the developing central nervous systemJournal of Neuroscience Research, 2001
- The Effects of Insulin-Like Growth Factors on Tumorigenesis and Neoplastic GrowthEndocrine Reviews, 2000
- The gene structure of the insulin-like growth factor familyProgress in Growth Factor Research, 1989
- IGF-2 stimulated growth mediated by the somatomedin type 2 receptorBiochemical and Biophysical Research Communications, 1987
- Insulin-Like Growth Factors/Somatomedins: Structure, Secretion, Biological Actions and Physiological RoleHormone Research, 1986
- Hepatotoxicity of mercaptopurineArchives of internal medicine (1960), 1968